Ankündigung • Apr 30
ageas SA/NV (ENXTBR:AGS) completed the acquisition of remaining 25% stake in AG Insurance SA/NV from BNP Paribas Fortis SA (ENXTBR:017250539). ageas SA/NV (ENXTBR:AGS) signed a framework agreement to acquire remaining 25% stake in AG Insurance SA/NV from BNP Paribas Fortis SA (ENXTBR:017250539) for €1.9 billion on December 7, 2025. A cash consideration of €1.9 billion will be paid by ageas SA/NV. As part of consideration, €1.9 billion is paid towards common equity of AG Insurance SA/NV. Upon completion, ageas SA/NV will own 100% stake in AG Insurance SA/NV. The transaction will be financed via equity placement of 18.5 million shares at a price if €60 per share valued at €1.1 billion to BNP Paribas Cardif and use of existing cash, existing financing facilities and flexibility in debt capital market.
The deal is expected to be finalized in 2Q26, after obtaining the necessary regulatory approvals.
ageas SA/NV (ENXTBR:AGS) completed the acquisition of remaining 25% stake in AG Insurance SA/NV from BNP Paribas Fortis SA (ENXTBR:017250539) on April 28, 2026. Pursuant the agreement, BNP Paribas nominated Renaud Dumora for appointment as a non-executive member of the Board of Directors of ageas SA/NV at the upcoming General Shareholders Meeting of May 20, 2026. Declared Dividend • Apr 26
Final dividend of €1.58 announced Shareholders will receive a dividend of €1.58. Ex-date: 3rd June 2026 Payment date: 5th June 2026 Dividend yield will be 3.9%, which is higher than the industry average of 3.4%. Sustainability & Growth Dividend is well covered by both earnings (41% earnings payout ratio) and cash flows (28% cash payout ratio). The dividend has increased by an average of 8.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to decline by 1.2% over the next 3 years. However, it would need to fall by 54% to increase the payout ratio to a potentially unsustainable range. Ankündigung • Apr 22
ageas SA/NV, Annual General Meeting, May 20, 2026 ageas SA/NV, Annual General Meeting, May 20, 2026, at 10:30 Romance Standard Time. Location: auditorium of ag insurance, ag campus rue du pont neuf 17, 1000 brussels, Belgium Reported Earnings • Apr 19
Full year 2025 earnings: EPS and revenues exceed analyst expectations Full year 2025 results: EPS: €9.10 (up from €6.10 in FY 2024). Revenue: €9.43b (up 11% from FY 2024). Net income: €1.71b (up 53% from FY 2024). Profit margin: 18% (up from 13% in FY 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 70%. Earnings per share (EPS) also surpassed analyst estimates by 9.8%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 19% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Feb 25
ageas SA/NV Proposes Gross Cash Dividend for 2025 ageas SA/NV proposed total gross cash dividend of EUR 3.75 for 2025, fully in line with its commitment, +7% vs 2024. Major Estimate Revision • Feb 04
Consensus EPS estimates increase by 12% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from €7.05 to €7.88. Revenue forecast unchanged at €11.6b. Net income forecast to grow 24% next year vs 8.8% growth forecast for Insurance industry in Belgium. Consensus price target broadly unchanged at €64.94. Share price rose 5.0% to €62.50 over the past week. Ankündigung • Dec 08
ageas SA/NV (ENXTBR:AGS) signed a framework agreement to acquire remaining 25% stake in AG Insurance SA/NV from BNP Paribas Fortis SA (ENXTBR:017250539) for €1.9 billion. ageas SA/NV (ENXTBR:AGS) signed a framework agreement to acquire remaining 25% stake in AG Insurance SA/NV from BNP Paribas Fortis SA (ENXTBR:017250539) for €1.9 billion on December 7, 2025. A cash consideration of €1.9 billion will be paid by ageas SA/NV. As part of consideration, €1.9 billion is paid towards common equity of AG Insurance SA/NV. Upon completion, ageas SA/NV will own 100% stake in AG Insurance SA/NV. The transaction will be financed via equity placement of 18.5 million shares at a price if €60 per share valued at €1,110 million to BNP Paribas Cardif and use of existing cash, existing financing facilities and flexibility in debt capital market.
The deal is expected to be finalized in 2Q26, after obtaining the necessary regulatory approvals. Declared Dividend • Nov 21
First half dividend of €1.05 announced Shareholders will receive a dividend of €1.05. Ex-date: 3rd December 2025 Payment date: 5th December 2025 Dividend yield will be 4.2%, which is higher than the industry average of 3.4%. Sustainability & Growth Dividend is covered by both earnings (56% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased by an average of 8.5% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 25% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Price Target Changed • Sep 04
Price target increased by 7.0% to €63.03 Up from €58.88, the current price target is an average from 10 analysts. New target price is 7.4% above last closing price of €58.70. Stock is up 25% over the past year. The company is forecast to post earnings per share of €7.01 for next year compared to €6.10 last year. Reported Earnings • Aug 28
First half 2025 earnings released: EPS: €3.66 (vs €3.50 in 1H 2024) First half 2025 results: EPS: €3.66 (up from €3.50 in 1H 2024). Revenue: €4.41b (up 2.3% from 1H 2024). Net income: €677.0m (up 5.5% from 1H 2024). Profit margin: 15% (in line with 1H 2024). Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • May 28
Upcoming dividend of €1.40 per share Eligible shareholders must have bought the stock before 04 June 2025. Payment date: 06 June 2025. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 6.1%. Lower than top quartile of Belgian dividend payers (6.8%). Higher than average of industry peers (4.2%). Declared Dividend • Apr 28
Final dividend of €1.40 announced Shareholders will receive a dividend of €1.40. Ex-date: 4th June 2025 Payment date: 6th June 2025 Dividend yield will be 4.6%, which is higher than the industry average of 3.4%. Sustainability & Growth Dividend is covered by earnings (57% earnings payout ratio) but not covered by cash flows (104% cash payout ratio). The dividend has increased by an average of 8.5% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 22% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Apr 11
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2024 results: EPS: €6.10 (up from €5.19 in FY 2023). Revenue: €8.51b (up 13% from FY 2023). Net income: €1.12b (up 17% from FY 2023). Profit margin: 13% (in line with FY 2023). Revenue exceeded analyst estimates by 21%. Earnings per share (EPS) missed analyst estimates by 9.4%. Revenue is forecast to grow 6.6% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 3% per year. Major Estimate Revision • Mar 27
Consensus revenue estimates increase by 37% The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from €14.0b to €19.3b. EPS estimate unchanged at €7.17. Net income forecast to grow 20% next year vs 9.7% growth forecast for Insurance industry in Belgium. Consensus price target broadly unchanged at €55.47. Share price was steady at €56.15 over the past week. Ankündigung • Mar 13
Allianz, ageas Reportedly Eye British Insurer esure Belgian insurer ageas SA/NV (ENXTBR:AGS) has retained advisors to explore a bid for British motor and home insurer esure Group plc, four people familiar with the matter told Reuters, as part of plans to consolidate the UK personal lines market. Allianz SE (XTRA:ALV) has also been working on an offer for esure in recent weeks, said two of the people, speaking on condition of anonymity. There will only be one main round of bidding, with a deadline in the next few weeks, the third person said, cautioning that a deal is not guaranteed. Bids for esure, owned by private equity firm Bain Capital, could be around GBP 1.5 billion ($1.94 billion), a fifth person said. All five people were speaking on condition of anonymity because the process is private. Spokespeople for Bain, Ageas, Allianz and esure declined to comment. Ankündigung • Feb 28
Ageas Sa/Nv Proposes Final Dividend ageas SA/NV proposed total dividend of EUR 3.50 per share. Final dividend of EUR 2.00 per share. Upcoming Dividend • Nov 27
Upcoming dividend of €1.05 per share Eligible shareholders must have bought the stock before 04 December 2024. Payment date: 06 December 2024. Payout ratio is a comfortable 56% but the company is paying out more than the cash it is generating. Trailing yield: 6.8%. Lower than top quartile of Belgian dividend payers (7.5%). Higher than average of industry peers (4.8%). Major Estimate Revision • Sep 29
Consensus revenue estimates increase by 78% The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from €7.20b to €12.8b. EPS estimate unchanged at €6.86. Net income forecast to grow 20% next year vs 15% growth forecast for Insurance industry in Belgium. Consensus price target broadly unchanged at €50.74. Share price rose 2.5% to €48.14 over the past week. Major Estimate Revision • Sep 04
Consensus revenue estimates decrease by 44%, EPS upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast fell from €12.9b to €7.20b. EPS estimate increased from €6.52 to €6.81 per share. Net income forecast to grow 20% next year vs 14% growth forecast for Insurance industry in Belgium. Consensus price target broadly unchanged at €49.87. Share price was steady at €46.68 over the past week. Reported Earnings • Sep 01
First half 2024 earnings released: EPS: €3.49 (vs €2.89 in 1H 2023) First half 2024 results: EPS: €3.49 (up from €2.89 in 1H 2023). Revenue: €4.31b (up 16% from 1H 2023). Net income: €642.0m (up 21% from 1H 2023). Profit margin: 15% (in line with 1H 2023). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Ankündigung • Aug 29
ageas SA/NV (ENXTBR:AGS) announces an Equity Buyback for €200 million worth of its shares. ageas SA/NV (ENXTBR:AGS) announces a share repurchase program. Under the program, the company will repurchase up to €200 million of its shares. The shares repurchased will be held in treasury. The program is valid till July 31, 2025. New Risk • Aug 29
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 11% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (11% operating cash flow to total debt). Minor Risk Dividend is not well covered by cash flows (160% cash payout ratio). Ankündigung • Aug 28
ageas SA/NV Declares Interim Gross Cash Dividend for the Fiscal Year 2024 ageas SA/NV declared a Interim gross cash dividend of EUR 1.50 per share for the fiscal year 2024. Major Estimate Revision • Aug 14
Consensus revenue estimates increase by 53% The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from €12.3b to €18.8b. EPS estimate unchanged at €6.52. Net income forecast to grow 24% next year vs 12% growth forecast for Insurance industry in Belgium. Consensus price target broadly unchanged at €48.99. Share price rose 2.2% to €42.48 over the past week. Ankündigung • May 31
ageas SA/NV to Report First Half, 2024 Results on Aug 28, 2024 ageas SA/NV announced that they will report first half, 2024 results on Aug 28, 2024 Upcoming Dividend • May 29
Upcoming dividend of €1.23 per share Eligible shareholders must have bought the stock before 05 June 2024. Payment date: 07 June 2024. Payout ratio is a comfortable 63% but the company is not cash flow positive. Trailing yield: 7.4%. Within top quartile of Belgian dividend payers (6.8%). Higher than average of industry peers (5.0%). Declared Dividend • Apr 24
Final dividend of €1.23 announced Shareholders will receive a dividend of €1.23. Ex-date: 5th June 2024 Payment date: 7th June 2024 Dividend yield will be 5.2%, which is higher than the industry average of 3.4%. Sustainability & Growth Dividend is covered by earnings (63% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 9.6% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 28% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Ankündigung • Mar 25
Ageas Plans Not to Make Further Offer for Direct Line Insurance ageas SA/NV (ENXTBR:AGS) announced that, following the two recent attempts to engage with the Board of Directors of Direct Line Insurance Group plc (LSE:DLG) ("Direct Line") in relation to the acquisition by Ageas of the entire issued and to be issued share capital of Direct Line, which were both rejected, it will not make an offer for Direct Line. As a result of this announcement, Ageas (and any persons acting in concert with it) will, except with the consent of the UK Panel on Takeovers and Mergers (the "Panel"), be bound by the restrictions contained in Rule 2.8 of the Code. For the purposes of Rule 2.8 of the Code, Ageas (and any persons acting in concert with it) reserves the right to announce an offer or possible offer for Direct Line or make or participate in an offer or possible offer for Direct Line and/or take any other action otherwise precluded under Rule 2.8 of the Code within six months of the date of this announcement in the following circumstances described in Note 2 to Rule 2.8 of the Code: (i) with the agreement of the Board of Directors of Direct Line; (ii) if a third party (including another publicly identified potential offeror) announces a firm intention to make an offer for Direct Line; (iii) if Direct Line announces a Rule 9 waiver or a reverse takeover (as defined in the Code); or (iv) if the Panel determines there has been a material change of circumstances. On 19 January 2024, Ageas provided the Board of Direct Line with an initial possible offer proposal (the "Initial Possible Offer") to acquire the entire issued and to be issued share capital of Direct Line. The terms of the Initial Possible Offer were improved on 9 March 2024 and set out in an announcement (the "Improved Possible Offer") on 13 March 2024. Ageas believes that the proposal, on these terms, would have created significant value for both groups of shareholders and other stakeholders. Throughout the entire process, Ageas has always sought engagement with Direct Line's Board. Ageas regrets that it has not been able to work collaboratively together with the Board of Directors of Direct Line towards a recommended Firm Offer. Ageas was not able to identify additional elements based on publicly available information that would justify significant adjustments to the terms of its possible offer. Therefore, consistent with its financial discipline, Ageas has decided not to make a Firm Offer. Ageas continues to believe in the underlying attractiveness and future opportunities of the UK personal lines sector and the role of Ageas UK in this market, underpinned by its successful turnaround over the last few years. Ageas UK will continue to execute its focused personal lines insurance strategy alongside its valued distribution partners. Ageas remains focused on the execution of its strategy, as a group of local companies outperforming in their markets, benefitting from synergies within the Group. Ageas re-iterates its confidence to deliver on its stated Impact24 financial and operating targets thanks to the strong performance of its operating entities. The Group's solid foundations underpin our attractive dividend growth ambitions in line with our stated Impact24 ambitions and beyond this strategic cycle. Hans De Cuyper, CEO of Ageas, said: "We had hoped to reach agreement on a jointly recommended Firm Offer together with the Direct Line Board. However, I am convinced that given the circumstances we took the right decision not to make an offer, staying true to who we are and what we stand for in terms of maintaining a friendly approach and respecting our financial discipline. I sincerely want to thank our employees and advisors who delivered outstanding performance exploring this opportunity, and our investors for their continued trust in our company". Ankündigung • Mar 16
BNP Paribas Reportedly Considers Buying Fosun's Ageas Stake BNP Paribas SA (ENXTPA:BNP) is considering a potential acquisition of Fosun International Limited (SEHK:656)’s stake in Belgian insurer ageas SA/NV (ENXTBR:AGS), according to people with knowledge of the matter. The French lender has been holding discussions on a possible purchase of Fosun’s holding in Ageas, said the people, who asked not to be identified because the information is private. Fosun has about a 10% interest in Ageas valued at roughly €750 million ($816 million) based on March 14, 2024 closing price, according to a regulatory filing. The figure includes its stock ownership as well as derivative holdings. The deliberations are ongoing and there’s no certainty they will lead to a transaction, the people said. Representatives for BNP and Ageas declined to comment. Fosun couldn’t immediately be reached for comment outside regular business hours. Bloomberg News reported last month that Fosun has been working with advisers to explore a sale of its Ageas stake. The Chinese conglomerate, which is backed by billionaire Guo Guangchang, has been accelerating a divestment push as it seeks to cut its debt load following a global acquisition spree. BNP’s potential move comes as Ageas pushes ahead with a contentious pursuit of a takeover of London-listed Direct Line Insurance Group Plc. The UK insurer said this week it had rejected a second takeover offer from Ageas valuing it at about £3.2 billion ($4.1 billion). Major Estimate Revision • Mar 06
Consensus revenue estimates decrease by 12% The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast fell from €7.36b to €6.44b. EPS estimate unchanged at €6.70 per share. Net income forecast to grow 30% next year vs 14% growth forecast for Insurance industry in Belgium. Consensus price target up from €47.22 to €48.71. Share price was steady at €38.42 over the past week. Ankündigung • Feb 29
Direct Line Soars as Ageas Mulls 3.10b Bid Shares in Direct Line Insurance Group plc (LSE:DLG) jumped on February 28, 2024 after Belgian insurer ageas SA/NV (ENXTBR:AGS) confirmed it was considering making an offer for the company. Shares in Direct Line, the Bromley, England-based motor and home insurer, soared 22% to 199.69 pence each in London on February 28, 2024. Ageas said the terms of the proposed cash and shares offer had an implied value of 233p per Direct Line share, representing a premium of 43% to 163.35 pence, closing price on February 27, 2024. The terms of the proposed bid are 100p in cash for each Direct Line share, and one new Ageas share for every 25.24047 Direct Line shares. Ageas said this would value Direct Line at around GBP 3.10 billion. A combination offered "compelling strategic and financial value for both Ageas and Direct Line shareholders", it added. Ageas highlighted the potential to drive operational improvements and efficiencies, in part through the removal of overlapping overhead costs after the integration of Ageas' and Direct Line'sUK businesses. Earlier February 28, 2024, Bloomberg reported that Direct Line had rebuffed an approach from Ageas, citing people familiar with the matter. Upcoming Dividend • Oct 18
Upcoming dividend of €1.05 per share at 7.7% yield Eligible shareholders must have bought the stock before 25 October 2023. Payment date: 27 October 2023. Payout ratio is a comfortable 60% but the company is not cash flow positive. Trailing yield: 7.7%. Lower than top quartile of Belgian dividend payers (7.8%). Higher than average of industry peers (5.2%). New Risk • Oct 02
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 0.01% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.01% per year for the foreseeable future. Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (7.3% net profit margin). Ankündigung • Sep 27
La Mutuelle Epargne Retraite Prévoyance Carac acquired French Life Insurance activities of Ageas. La Mutuelle Epargne Retraite Prévoyance Carac signed an agreement to acquire French Life Insurance activities of Ageas on April 21, 2023. Ageas’s French Life and Pension activities consist of Ageas France, Ageas Retraite, Ageas Patrimoine and Sicavonline. The transaction is subject to regulatory approval. French Life Insurance activities generated revenue of €6.1 million in 2022. The transaction is expected to be closed during third quarter of 2023.
La Mutuelle Epargne Retraite Prévoyance Carac completed the acquisition of French Life Insurance activities of Ageas on September 25, 2023. All regulatory approvals regarding the sale of French life insurance, savings and pension business to La Mutuelle Epargne Retraite Prévoyance Carac have been obtained. Major Estimate Revision • Sep 21
Consensus revenue estimates decrease by 15%, EPS upgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from €10.5b to €9.00b. EPS estimate increased from €5.65 to €5.79 per share. Net income forecast to grow 22% next year vs 16% growth forecast for Insurance industry in Belgium. Consensus price target broadly unchanged at €45.47. Share price fell 2.1% to €39.25 over the past week. Reported Earnings • Sep 01
First half 2023 earnings released: EPS: €2.89 (vs €3.05 in 1H 2022) First half 2023 results: EPS: €2.89 (down from €3.05 in 1H 2022). Revenue: €5.30b (up 49% from 1H 2022). Net income: €531.0m (down 5.7% from 1H 2022). Profit margin: 10.0% (down from 16% in 1H 2022). Revenue is expected to decline by 3.0% p.a. on average during the next 3 years, while revenues in the Insurance industry in Europe are expected to grow by 5.1%. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 1% per year. New Risk • Aug 04
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 2.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Earnings are forecast to decline by an average of 2.6% per year for the foreseeable future. Minor Risk Paying a dividend despite having no free cash flows. Upcoming Dividend • May 24
Upcoming dividend of €1.05 per share at 7.4% yield Eligible shareholders must have bought the stock before 31 May 2023. Payment date: 02 June 2023. Payout ratio is a comfortable 55% but the company is not cash flow positive. Trailing yield: 7.4%. Within top quartile of Belgian dividend payers (6.7%). Higher than average of industry peers (5.1%). Ankündigung • May 13
ageas SA/NV to Report First Half, 2023 Results on Aug 30, 2023 ageas SA/NV announced that they will report first half, 2023 results on Aug 30, 2023 Reported Earnings • Apr 17
Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2022 results: EPS: €5.49 (up from €4.52 in FY 2021). Revenue: €9.87b (down 27% from FY 2021). Net income: €1.01b (up 20% from FY 2021). Profit margin: 10% (up from 6.3% in FY 2021). The increase in margin was driven by lower expenses. Combined ratio: 96.5% (up from 95.4% in FY 2021). Revenue missed analyst estimates by 6.8%. Earnings per share (EPS) exceeded analyst estimates by 6.9%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Reported Earnings • Feb 25
Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2022 results: EPS: €5.49 (up from €4.52 in FY 2021). Revenue: €10.4b (down 23% from FY 2021). Net income: €1.01b (up 20% from FY 2021). Profit margin: 9.7% (up from 6.3% in FY 2021). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 7.0%. Earnings per share (EPS) exceeded analyst estimates by 6.9%. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Ankündigung • Jan 12
ageas SA/NV to Report Fiscal Year 2022 Final Results on Mar 31, 2023 ageas SA/NV announced that they will report fiscal year 2022 final results on Mar 31, 2023 Ankündigung • Jan 02
ageas SA/NV to Report Fiscal Year 2022 Results on Feb 22, 2023 ageas SA/NV announced that they will report fiscal year 2022 results on Feb 22, 2023 Upcoming Dividend • Oct 20
Upcoming dividend of €1.05 per share Eligible shareholders must have bought the stock before 26 October 2022. Payment date: 28 October 2022. Payout ratio is on the higher end at 79% but the company is not cash flow positive. Trailing yield: 7.5%. Within top quartile of Belgian dividend payers (7.5%). Higher than average of industry peers (5.8%). Upcoming Dividend • May 25
Upcoming dividend of €1.93 per share Eligible shareholders must have bought the stock before 01 June 2022. Payment date: 03 June 2022. Payout ratio is a comfortable 62% but the company is not cash flow positive. Trailing yield: 6.0%. Within top quartile of Belgian dividend payers (5.8%). Higher than average of industry peers (5.4%). Reported Earnings • May 22
First quarter 2022 earnings: Revenues miss analyst expectations First quarter 2022 results: Revenue: €2.25b (down 35% from 1Q 2021). Net income: €271.8m (down 8.1% from 1Q 2021). Profit margin: 12% (up from 8.6% in 1Q 2021). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 100%. Over the next year, revenue is expected to shrink by 19% compared to a 16% growth forecast for the industry in Belgium. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 1% per year. Reported Earnings • Apr 06
Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2021 results: EPS: €4.52 (down from €6.07 in FY 2020). Revenue: €13.5b (up 12% from FY 2020). Net income: €845.0m (down 26% from FY 2020). Profit margin: 6.3% (down from 9.5% in FY 2020). The decrease in margin was driven by higher expenses. Combined ratio: 95.4% (up from 91.3% in FY 2020). Revenue missed analyst estimates by 6.6%. Earnings per share (EPS) exceeded analyst estimates by 9.1%. Over the next year, revenue is expected to shrink by 25% compared to a 16% growth forecast for the insurance industry in Belgium. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has remained flat. Major Estimate Revision • Feb 25
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast fell from €9.91b to €8.68b. EPS estimate increased from €5.26 to €5.44 per share. Net income forecast to grow 32% next year vs 4.2% growth forecast for Insurance industry in Belgium. Consensus price target broadly unchanged at €49.91. Share price rose 3.0% to €44.05 over the past week. Reported Earnings • Aug 12
Second quarter 2021 earnings released: EPS €0.60 (vs €1.78 in 2Q 2020) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €3.29b (down 7.8% from 2Q 2020). Net income: €111.1m (down 67% from 2Q 2020). Profit margin: 3.4% (down from 9.5% in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Reported Earnings • Apr 05
Full year 2020 earnings released: EPS €6.07 (vs €5.09 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €12.0b (down 19% from FY 2019). Net income: €1.14b (up 17% from FY 2019). Profit margin: 9.5% (up from 6.6% in FY 2019). The increase in margin was driven by lower expenses. Combined ratio: 91.3% (down from 95.0% in FY 2019). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Feb 22
New 90-day high: €47.23 The company is up 10.0% from its price of €43.00 on 24 November 2020. The Belgian market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €69.52 per share. Is New 90 Day High Low • Jan 04
New 90-day high: €44.34 The company is up 22% from its price of €36.28 on 06 October 2020. The Belgian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €69.57 per share. Is New 90 Day High Low • Dec 16
New 90-day high: €43.36 The company is up 15% from its price of €37.78 on 17 September 2020. The Belgian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €77.16 per share.